Register entry

Shanghai Ambiopharm, Inc

Data as of · How to read this entry

Registered sites
1
Active NDC listings
3
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Shanghai Ambiopharm, IncNo. 399 Yingong Road, Fengxian District Industrial Park, Shanghai, Shanghai 201417, China (CHN)Analytical testing, Active ingredient (API) manufacture3006494603529125699
Catalogue

Drug listings by form and route

3

3 active NDC listings: 3 bulk ingredient. By marketing category: BULK INGREDIENT 3.

Dosage formNDCs
powder3
RouteNDCs
Labeller name on the listingNDCs
shanghai ambiopharm, inc3
Catalogue

Marketed products

3
BrandGeneric nameForm / routeNDC
-Liraglutidepowder41524-0011BULK INGREDIENT
-Semaglutidepowder41524-0012BULK INGREDIENT
-Teduglutidepowder41524-0009BULK INGREDIENT
Neighbours

Registered in the same town

12
Compare

Comparable companies in China

Enquiry

Common questions

Is Shanghai Ambiopharm, Inc FDA approved?
Shanghai Ambiopharm, Inc holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Shanghai Ambiopharm, Inc's drugs manufactured?
The FDA register lists Shanghai. Registered operations: analytical testing, active ingredient (API) manufacture.
What drugs does Shanghai Ambiopharm, Inc make?
3 products are listed under Shanghai Ambiopharm, Inc in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.